𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells

✍ Scribed by Ching-Han Yu; Shu-Fen Kan; Hsiao-Fung Pu; Eileen Jea Chien; Paulus S. Wang

Book ID
108586306
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
526 KB
Volume
99
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CK2 signaling in androgen-dependent and
CK2 signaling in androgen-dependent and -independent prostate cancer
✍ Guixia Wang; Kashif A. Ahmad; Gretchen Unger; Joel W. Slaton; Khalil Ahmed πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 190 KB

## Abstract Protein serine/threonine kinase casein kinase 2 (CK2) is a key player in cell growth and proliferation but is also a potent suppressor of apoptosis. CK2 has been found to be dysregulated in all the cancers that have been examined, including prostate cancer. Investigations of CK2 signali

Role of antioxidant systems in human and
Role of antioxidant systems in human androgen-independent prostate cancer cells
✍ Suzuki, Yasutomo; Kondo, Yukihiro; Himeno, Seiichiro; Nemoto, Kaoru; Akimoto, Ma πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 228 KB πŸ‘ 2 views

## BACKGROUND. Most prostate cancer cells respond to initial hormonal therapy; however, some of them eventually acquire resistance to the hormonal therapy. Hormone-independent prostate cancer usually exhibits resistance to chemotherapy and radiotherapy. Antioxidant systems are known to be involved

5Ξ±-androstane-3Ξ±,17Ξ²-diol supports human
5Ξ±-androstane-3Ξ±,17Ξ²-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: Implication of androgen-independent prostate cancer progression
✍ Qing Yang; Mark A. Titus; Kar-Ming Fung; Hsueh-Kung Lin πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 323 KB πŸ‘ 1 views

## Abstract Androgen and androgen receptor (AR) are involved in growth of normal prostate and development of prostatic diseases including prostate cancer. Androgen deprivation therapy is used for treating advanced prostate cancer. This therapeutic approach focuses on suppressing the accumulation of